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Hospital readmission is common among children with complicated severe acute mal-
nutrition (cSAM) but not well‐characterised. Two distinct cSAM phenotypes, maras-
mus and kwashiorkor, exist, but their pathophysiology and whether the same
phenotype persists at relapse are unclear. We aimed to test the association between
cSAM phenotype at index admission and readmission following recovery. We per-
formed secondary data analysis from a multicentre randomised trial in Kenya with
1‐year active follow‐up. The main outcome was cSAM phenotype upon hospital read-
mission. Among 1,704 HIV‐negative children with cSAM discharged in the trial, 177
children contributed a total of 246 readmissions with cSAM. cSAM readmission
was associated with age<12 months (p = .005), but not site, sex, season, nor cSAM
phenotype. Of these, 42 children contributed 44 readmissions with cSAM that
occurred after a monthly visit when SAM was confirmed absent (cSAM relapse).
cSAM phenotype was sustained during cSAM relapse. The adjusted odds ratio for
presenting with kwashiorkor during readmission after kwashiorkor at index admission
was 39.3 [95% confidence interval (95% CI) [2.69, 1,326]; p = .01); and for presenting
with marasmus during readmission after kwashiorkor at index admission was 0.02
(95% CI [0.001, 0.037]; p = .01). To validate this finding, we examined readmissions
to Kilifi County Hospital, Kenya occurring at least 2 months after an admission with
cSAM. Among 2,412 children with cSAM discharged alive, there were 206
readmissions with cSAM. Their phenotype at readmission was significantly influenced
by their phenotype at index admission (p < .001). This is the first report describing the
phenotype and rate of cSAM recurrence.
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Key messages
• Severe malnutrition phenotype was persistent such that a
child readmitted for kwashiorkor would be likely to be
readmitted with kwashiorkor again.
• Readmission with complicated severe malnutrition after
clinical stabilisation occurred in 10.2% of children at a
rate of 15.9 (95% CI [13.9, 18.0]) per 100 child years.
• Severe malnutrition phenotype did not affect the
readmission rate, but children below 12 months old had
higher risks of readmission with complicated severe
acute malnutrition.
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Severe acute malnutrition (SAM) remains a serious public health bur-
den and contributes to more than a third of all deaths among children
under 5 years (Black et al., 2013; UNICEF/WHO/World Bank, 2017).
In 2016, global estimates suggested that nearly 52 million children
under 5 years old were wasted (acutely malnourished), of which 17
million were severely wasted (UNICEF/WHO/World Bank, 2017).
SAM increases susceptibility to diseases and infections. Hence, many
of these children also suffer from common illnesses, which can impede
their recovery. The combination of SAM and infection, known as com-
plicated SAM (cSAM), if untreated, forms a vicious downward spiral
where both conditions exacerbate each other (Ambrus & Ambrus,
2004). SAM is clinically categorised into two entirely different pheno-
types: marasmus (severe wasting), which is characterised by muscle
atrophy; and kwashiorkor (oedematous malnutrition), characterized
by oedema, fatty liver, hair depigmentation, desquamating skin lesions,
and behavioural changes; some children present with both pheno-
types concurrently (“marasmic–kwashiorkor”; Bhutta et al., 2017). In
the absence of understanding of their pathophysiological differences,
treatment protocols for cSAM are the same for both phenotypes
(Manary & Brewster, 2000).
Current guidelines recommend that children admitted with cSAM
are discharged and transferred to community care when their medical
complications, including oedema, are resolving, they are clinically well
and alert, and have good appetite, rather than hospital discharge being
based on anthropometric criteria (WHO, 2019). However, children
with cSAM experience a high rate of mortality and readmission in
the months following hospital discharge especially in sub‐Saharan
Africa (Berkley et al., 2016; Chhibber et al., 2015; Dubray et al.,
2008; Kerac et al., 2009; Moisi et al., 2011; Ngari et al., 2017; Trehan
et al., 2013; Veirum, Sodeman, Biai, Hedegård, & Aaby, 2007; Wiens
et al., 2013; Wiens et al., 2015). Recent systematic reviews reported
paediatric post‐discharge mortality rates in resource‐poor countries
of up to 18% that may exceed in‐hospital mortality rates in many set-
tings (Nemetchek et al., 2018; Wiens et al., 2013). Further, post‐
discharge relapse is poorly defined and infrequently systematically
measured in programmes, and therefore less understood. A recent
systematic review showed that the proportion of children who relapse
following SAM treatment varies greatly from 0 to 37% across different
lengths of time following discharge and with varying loss to follow‐up,
but with the highest proportions occurring in the first 6 months
postdischarge (Stobaugh et al., 2018). Such relapse rates are higher
when the group with moderate acute malnutrition are considered.
The review also highlighted the lack of a standard definition of relapse
that limits comparability even among the few studies that have quan-
tified post‐discharge relapse (Stobaugh et al., 2018). Low anthropom-
etry at admission and discharge following an acute illness were
highlighted as risk markers for relapse.
Most research on SAM has focussed on its causes, treatment, and
short‐term consequences, whereas assessment of overall health and
nutrition after discharge either from a hospital or community‐based
(Community‐Based Management of Acute Malnutrition) nutritionprogrammes is limited. Furthermore, only few studies that evaluated
post‐discharge outcomes have focussed on relapse to cSAM, which
can be defined as a child presenting with cSAM following discharge
(or default) from cSAM treatment (Stobaugh et al., 2018). Data on hos-
pital readmissions with SAM following both clinical and nutritional
rehabilitation is less common. It is also unclear whether a child pre-
senting with one phenotype of SAM will present the same phenotype
upon relapse to SAM. This knowledge could help better understand
the natural history of the two phenotypes.
We evaluated readmissions with cSAM among children who were
discharged after index hospitalisation with cSAM using data from a
multicentre randomised controlled trial with active follow‐up for 1
year after discharge (Berkley et al., 2016) to determine whether there
was an association between a child's phenotype at index admission
and the phenotype at readmission. Findings on association between
the index admission and readmission phenotypes were validated using
data from a longer term clinical and demographic surveillance at one
site in Kenya (Scott et al., 2012). We also estimated the incidence of
readmission with cSAM in the randomised trial.2 | METHODS
2.1 | Study design and settings
We performed secondary analysis of data from a randomised con-
trolled trial that tested the efficacy of daily co‐trimoxazole prophylaxis
in reducing post‐discharge mortality among HIV‐uninfected children
with cSAM in two urban (Mombasa and Nairobi) and two rural (Kilifi
and Malindi) hospitals in Kenya (Berkley et al., 2016). Discharge was
standardised across site, based on World Health Organization
(WHO) guidelines (2013) through training and monitoring. Children
with cSAM were actively linked to therapeutic and supplementary
feeding programmes upon hospital discharge. Children were then
actively followed up for a total of 1 year, monthly in the first 6 months,
and every 2 months until Month 12 for growth, readmission, or death.
Study participants were traced at home if they defaulted and the loss
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effect on reducing mortality or hospital readmission.
For validation, we analysed a data set of children admitted to
Kilifi County Hospital (KCH), Kenya from 2002 to 2016 with cSAM,
and subsequent readmissions at KCH were detected through linkage
with a unique identifier on a population database for those living
within the Kilifi Health and Demographic Surveillance System
(KHDSS) area, with quarterly household enumeration, as previously
described (Ngari et al., 2018b; Scott et al., 2012). All the study
hospitals offered inpatient and outpatient care according to Kenya
(2009) national and WHO (2013) guidelines, and discharge was
standardised based on WHO guidelines (2013). Children with cSAM
were actively linked to therapeutic and supplementary feeding
programmes upon hospital discharge. Missing follow‐up visits and
needing to be traced by a fieldworker making a home visit was asso-
ciated with readmission (with any condition, not just complicated
SAM) and death, as previously published (Berkley et al., 2016; Ngari
et al., 2018a).2.2 | Study population
The randomised clinical trial recruited children with cSAM aged 2–59
months who had completed the initial “stabilisation” phase of cSAM
inpatient treatment. Children were eligible for the trial if mid upper
arm circumference (MUAC) <11.5 cm for those aged 6–59 months,
MUAC <11 cm for those aged <6 months, or having nutritional
oedema at any age (defined in 2013 WHO guidelines). HIV‐infected
children were excluded because they would already be on open‐label
co‐trimoxazole prophylaxis. Children were included in the analysis if
they were readmitted with cSAM. Children with SAM but not needing
clinical care were therefore not included in the analysis.
From the KCH admissions database, we included children admitted
with cSAM between 2002 and 2016 aged 2–59 months and
discharged alive. The cSAM definition used among the KCH study par-
ticipants was the same as for the trial participants. Acquiring an illness
postdischarge is common among children with SAM but it is also pos-
sible that a subclinical condition persisted even after clinical care,
which either only manifested or worsened postdischarge. As such, this
would not be a new episode of disease. To reduce this bias for the
analysis of readmission phenotype for the KCH admissions database,
which did not have active follow‐up of patients post‐discharge, we
limited the analysis to readmissions that occurred at least 2 months
after discharge from the hospital. Children who did not require
hospitalisation or those that were hospitalised in other hospital were
not included in the analysis.2.3 | Variables
The primary outcome was hospital readmission SAM phenotype
(kwashiorkor or marasmus). Kwashiorkor was regarded as having
nutritional oedema regardless of wasting (i.e., marasmic–kwashiorkor).
Children without nutritional oedema and with either MUAC <11.5 cm
(or<11 cm if age <6 months) or weight‐for‐length/height <−3 wereconsidered as marasmus. The other outcome of interest was incidence
of readmission with cSAM in the randomised trial. The exposures
examined were age, sex, SAM phenotype at index admission, recruit-
ment site (for the clinical trial), season (rainy or dry) at admission,
and randomisation arm (for the clinical trial). To account for seasonal-
ity of admissions, rainy season was considered as admission during
March to May and October to December, whereas dry season was
the remaining months of the year (Yang, Seager, Cane, & Lyon, 2014).2.4 | Data sources and measurement
In both the trial and at KCH, children were weighed using electronic
scales (seca 825), length (children <2 years) was measured using an
infantometer (seca 416), height (children 2 or more years old) using a
stadiometer (seca 215), and MUAC using a nonstretch dedicated
insertion tape Teaching‐Aid at Low Cost (TALC). Weight‐for‐length/
height and length‐for‐age z‐scores were calculated using the 2006
WHO children growth references. Kwashiorkor was diagnosed by
trained clinicians as pitting oedema: generalised on both feet, legs,
hands, arms, and face; both feet plus lower legs, hands, or lower arms;
or both feet only. Children recruited in the randomised trial were in
follow‐up for 12 months with anthropometric measurements taken
at every scheduled visit and during hospital readmission. For children
admitted to KCH, anthropometric measurements were conducted at
each admission, and there were no planned research follow‐ups with
anthropometry.2.5 | Study size
All children recruited in the trial and admitted at KCH with cSAM dur-
ing the study period were included in the analysis. Therefore, no for-
mal sample size was calculated. For the randomised trial, the sample
size used had 90% power to detect a one‐third reduction in mortality,
accounting for loss to follow‐up, assuming 15% mortality in the con-
trol arm. For the analysis of admission data from the KCH, all SAM
admissions were included in the analysis. A total of 1,778 participants
were enrolled in the randomised trial, of whom 1,704 were discharged
alive and followed up (Figure 1a). In the KCH validation data set, 2,615
children were admitted with cSAM who were resident within the
KHDSS (Figure 1b).2.6 | Data analysis
Data analyses were performed using R statistical software version 3.6
(R: A language and environment for statistical computing, 2009).
Extreme weight‐for‐length/height z‐score ±6 from the median z‐score
of 0 were excluded unless the child had kwashiorkor. For the children
admitted at KCH, any admission with missing anthropometric mea-
surements were excluded.
In order to assess the association between cSAM phenotype at
index admission and the phenotype during cSAM readmission, we
identified children from the randomised trial who were readmitted
FIGURE 1 Recruitment flow diagram for the secondary analysis of the clinical trial (a) and the admissions data obtained from the Kilifi County
Hospital (b). cSAM, complicated severe acute malnutrition; KCH, Kilifi County Hospital; KHDSS, Kilifi Health and Demographic Surveillance
System; SAM, severe acute malnutrition
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prior to their readmission with cSAM.
Because of this condition, the time elapsed from hospital discharge
to readmission was also influenced by the rate of recovery of the child
from SAM. Hence, instead of a time‐to‐event analysis, a mixed logistic
regression model was used to evaluate the association between cSAM
phenotype at index admission and readmission with site of recruit-
ment set as random effect. The adjusted odds ratios for readmission
with kwashiorkor (versus no readmission with kwashiorkor) and read-
mission with marasmus (versus no readmission with marasmus) were
calculated separately.
To validate findings regarding the effect of cSAM phenotype at
index admission on phenotype at subsequent admissions from the
randomised trial, we examined data obtained from all cSAM admis-
sions at the KCH. We used logistic regression to validate whether
there was an association between index readmission and readmission
cSAM phenotypes.
Using the clinical trial data only, the incidence of readmission with
cSAM in the randomised trial was calculated as the number of
readmissions with cSAM per 100 child‐years of observation: the time
from date of index discharge to date of death, loss to follow up, or
completing study. Since post‐discharge deaths and loss to follow‐up
would preclude the probability of observing hospital readmission, we
treated these events as competing risks. Then, to examine the associ-
ation between SAM phenotype at index admission on the hospital
readmission rate, we used the Fine‐Gray competing risk analysismethod (Fine & Gray, 1999) implemented using the timereg package
for R (Scheike & Zhang, 2011) instead of the more conservative Cox
regression models and reported the effects using subdistribution haz-
ards ratios. Because a child could have more than one hospital read-
mission, the model used accounted for multiple events and was
adjusted for age, sex, randomised arm, and site with robust standard
errors.2.7 | Study approvals
The trial and secondary analyses were approved by the Kenyan
national ethics committee, KEMRI‐ SERU (SSC 1562) and the Oxford
Tropical Research Ethics Committee (OXTREC reference 18‐09). The
trial was registered at clinicaltrials.gov (NCT00934492). Analysis of
the KCH admissions and KHDSS data was approved by the Kenya
Medical Research Institute (KEMRI) Scientific Ethics Review Unit
(SCC 2778).3 | RESULTS
3.1 | Study participants
In the original randomised trial, 1,778 children with cSAM were
enrolled when they had reached stabilisation. Sixty children (3.4%)
died, and two withdrew consent before index discharge and were
TABLE 1 Characteristics of participants in the randomised trial
analysed in this study
Characteristics
n 1,704
Median age (mo.) at admission [IQR] 11 [7–16]
Girls n (%) 812 (49)
Nutritional oedema n (%) 285 (17)
MUACa, cm mean ± SD 10.6 ± 1.1
Weight‐for‐length z‐score ± SDb −3.3 ± 1.2
Length‐for‐age z‐score ± SD −2.9 ± 1.7
Recruitment site n (%)
Kilifi 145 (8)
Malindi 255 (15)
Mbagathi 489 (29)
Mombasa 812 (48)
n randomised to co‐trimoxazole prophylaxis 851 (50)
Post‐discharge mortality n (%)c 197 (12)
Abbreviation: IQR, interquartile ratio; mo., month; SD, standard deviation.
aMid‐upper arm circumference.
bExcluding kwashiorkor cases.
cChildren were recruited after “stabilisation” phase hence the low inpatient
mortality.
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followed up (Figure 1a), nine children were lost to follow‐up, and three
withdrew consent within 2 weeks after discharge and were also
excluded from this analysis. We therefore included 1,704 children in
follow‐up for a total of 1,504.19 child‐years of observation (Figure 1
a). Their median age (interquartile ratio) was 11 (7–16) months, and
812 (49%) were female. The mean (SD) MUAC was 10.6 (1.06) cm,
and 285 (17%) had kwashiorkor. Baseline study participant character-
istics are shown in Table 1.FIGURE 2 Phenotype (kwashiorkor or marasmus) during index admissi
children were readmitted with severe acute malnutrition (SAM) after nutri
second readmission with SAM occurred after 1‐month follow‐up where thA total of 31,807 children were admitted to the KCH from 2002 to
2016, of which 7,168 (23%) met the inclusion criteria for cSAM; 5,515
(77%) were marasmic; and 1653 (23%) had kwashiorkor. Of the chil-
dren admitted with cSAM, 945 (13%) died before discharge and were
excluded. Furthermore, 3,595 children who lived outside the KHDSS
surveillance area and nine patients who had missing anthropometry
at index admission were also excluded from the analysis. We,
therefore, included 2,651 children in this analysis (Figure 1b). Their
median age (interquartile ratio) was 13 (6–23) months, and 1,199
(45%) were female. The mean MUAC (including kwashiorkor cases)
was 11.5 cm (SD 1.8), and 509 (19%) had oedema (supporting informa-
tion Table S1).3.2 | Association between SAM phenotype at index
admission and phenotype upon readmission with
cSAM
There were 246 readmissions with cSAM in the trial. Of these, 42 chil-
dren were readmitted with cSAM readmission 44 times after a
monthly visit where they were confirmed not to have SAM prior to
being readmitted; 34 and 8 had marasmus and kwashiorkor at index
admission, respectively. Of these children, 29/34 (85%) and 5/8
(62%) admitted with marasmus and kwashiorkor, respectively, at index
presented with the same phenotype upon readmission with cSAM
(Figure 2). The adjusted odds ratio of presenting with kwashiorkor
during readmission when the patient had kwashiorkor at index admis-
sion was 39.3 [95% confidence interval (95% CI) [2.69, 1326]; p = .01].
On the other hand, the adjusted odds ratio of presenting with maras-
mus during readmission when having kwashiorkor at index admission
was odds ratio 0.02 (95% CI [0.001, 0.32]), p = .01. Phenotypic con-
cordance was not influenced by age (p = .19), sex (p = .14), season (p
= .98), nor arm in the clinical trial (p = .93). Recruitment site was set
as a random effect in the mixed logistic model.on and during readmissions after nutritional recovery. A total of 42
tional recovery, and 2 children were readmitted with SAM twice. The
e child was not SAM
FIGURE 3 Phenotype (kwashiorkor or marasmus) during index admission and during consecutive complicated severe acute malnutrition
readmissions with at least 2 months between admissions based on admissions data of the Kilifi County Hospital from 2002–2016 of children
admitted with severe acute malnutrition aged 2–59 months residing within the scope of the Kilifi Health Demographic Surveillance and Survey
TABLE 2 Estimates for the Fine‐Gray hazard model to assess rates
of hospital readmissions with complicated severe acute malnutrition
accounting for competing risks in the clinical trial (death and lost‐to‐
follow‐up)
Covariates
Sub‐
distribution
hazard ratio
95%
Confidence
interval
Robust
standard
error p
Marasmus Reference
Kwashiorkor 1.31 0.76–2.26 1.31 .32
Age:
<1 year 1.73 1.13–2.64 1.24 <.01
1–2 years Reference
>2 years 1.40 0.75–2.63 1.37 .28
Female Reference
Male 1.07 0.74–1.52 1.19 .42
Site:
Kilifi Reference
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2,651 children in the analysis that comprised those discharged from
KCH after cSAM treatment and residing within the KHDSS area. A
total of 206 (7.8%) children were readmitted with SAM between 2
and 12 months postdischarge. Of the 2,412 children discharged alive
with marasmus at index, 187 (7.8%) were readmitted with cSAM. A
majority (165/187, 88%) retained marasmus status at the readmission
whereas 22/187 (12%) returned with kwashiorkor on their first read-
mission (Figure 3). Of the 509 children discharged alive with kwashior-
kor at index admission, 19 (3.7%) were readmitted with cSAM. A
majority (14/19, 74%) were readmitted with kwashiorkor and 5/19
(23%) returned with marasmus. Consistent with the results obtained
from the randomised trial data, there was a significant association (p
< .001) between phenotype at index admission and the phenotype
upon readmission with cSAM, accounting for age, sex, and MUAC at
index admission. This association was also observed between first
readmission and second readmission (p = .03) separated by at least 2
months.Malindi 0.62 0.29–1.31 1.46 .21
Mbagathi 0.97 0.49–1.90 1.40 .93
Mombasa 0.80 0.42–1.50 1.38 .49
Season:
Dry Reference
Rainy 1.31 0.93–1.83 1.19 .11
Arm in original trial
Treatment Reference
Placebo 1.29 0.92–1.81 1.89 .143.3 | Readmissions with complicated severe acute
malnutrition
In the trial, a total of 729 readmissions occurred among 658/1704
(37%) children during follow‐up. Of the 729 readmissions, 246
readmissions involved cSAM among 174/1704 (10.2%) children during
1,504.19 child years of follow‐up, a rate of 15.9 (95% CI [13.9, 18.0])
per 100 child years. One‐hundred and thirteen (113) children were
readmitted once with cSAM, 57 twice, and 3 children were readmitted
FIGURE 4 Cumulative hazard of
readmission with cSAM based on the Fine‐
Gray model. Broken lines signify 95%
confidence intervals
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tion between SAM phenotype at index admission and rate of cSAM
readmission (adjusted subdistribution hazards ratios = 1.3, 95% CI
[0.8, 2.3] p = .32) after adjusting for age, sex, site, season and arm in
the randomised trial (Table 2). Age however, especially being less than
12 months old, was significantly associated with cSAM readmission.
Figure 4 shows the cumulative hazard plot for cSAM readmission,
which shows the risk of any readmission with cSAM is 12%, within 1
year postdischarge.4 | DISCUSSION
This study aimed to test the association between cSAM phenotype at
index admission and readmission following recovery. Our results
showed an association between the phenotype at index admission
and readmission phenotype for cSAM indicating that SAM phenotype
persists in the same children during relapses. Findings on phenotype
persistence were confirmed in a separate validation data set compris-
ing of children admitted to a rural county hospital in a natural setting.
It is possible that SAM phenotype could be persistent due to the fact
that the child goes back to the same environment, household condi-
tions, and perhaps dietary habits after discharge from the hospital.
However, a genetic predisposition to a certain phenotype has previ-
ously been suggested, relating to disruption of intestinal sulphated gly-
cosaminoglycans in kwashiorkor (and not in marasmus), which the
authors ascribed to a potentially genetically influenced lower
sulphated glycosaminoglycans synthesis rate (Amadi et al., 2009).
The role of the gut microbial composition also cannot be discounted
as children with SAM have been found to harbour a persistent imma-
ture gut microbiota composition even after nutritional intervention
(Subramanian et al., 2014), which could also influence the phenotype
that a child with SAM relapses. We also found that the index admis-
sion phenotype of marasmus or kwashiorkor did not alter the risk of
readmission with cSAM, but children younger than 1 year old were
more likely to be readmitted with cSAM.
Of the few studies that examined nutritional and clinical rehabili-
tation of children with SAM treated in nutritional rehabilitation units
or hospital facilities, reported incidences where children relapsed toSAM varied from 0–13% (Beau, 1993; Briend et al., 2005; Khanum,
Ashworth, & Huttly, 1998; Pécoul, Soutif, Hounkpevi, & Ducos,
1992; Perra & Costello, 1995; van Roosmalen‐Wiebenga, Kusin, &
de With, 1987). However, in these studies, it is unclear whether these
children also developed clinical complications in addition to SAM
because they were conducted prior to the current classification of
complicated and uncomplicated SAM. Two studies explicitly noted
that children that relapsed to SAM were readmitted to the hospital
although any clinical comorbidities were not specified (Khanum
et al., 1998; van Roosmalen‐Wiebenga et al., 1987). In the study of
Khanum et al. (1998), children that developed oedema or with
<60% of weight‐for‐height were readmitted together with
nonmalnourished children with medical emergencies, although it
was unclear whether the malnourished children needed hospital care.
In the study of van Roosmalen‐Wiebenga et al. (1987), children that
relapsed were readmitted to the hospital, although definition of
relapse and their discharge criteria were unclear. Treatment guide-
lines have also changed since 1987, which means that the results of
their study may need to be re‐evaluated. Although data on the mor-
tality and relapse to SAM of children managed in Community‐Based
Management of Acute Malnutrition programmes (uncomplicated
SAM) have been reported (O'Sullivan, Lelijveld, Rutishauser‐Perera,
Kerac, & James, 2018; Stobaugh et al., 2018), only a few papers
reported nutritional outcomes of children after treatment from cSAM
(Fergusson et al., 2009; Kerac et al., 2009; Kerac et al., 2014; Lelijveld
et al., 2016).
The goal of SAM treatment also includes the reduction of suscep-
tibility to life‐threatening infections, restoration of a healthy body
composition, and improvement in neurocognitive status (Ngari et al.,
2018a). However, children with SAM remain at risk of developing
severe illness and/or infections after treatment of clinical complica-
tions and discharged from hospital (Berkley et al., 2016; Chisti et al.,
2014; Kerac et al., 2014; Ngari et al., 2018a). A study by Kerac et al.
(2014) that followed 1,024 children 1 year post‐discharge reported
5% hospital readmissions but 42% deaths, whereas Khanum et al.
(1998) reported 1.2% emergency hospital readmissions. These studies
however only captured one readmission event per child. Accounting
for multiple hospital readmissions, a previous report recorded 616
nonfatal admissions to hospital and 3,266 nonfatal episodes of illness
8 of 10 GONZALES ET AL.
bs_bs_bannerpost‐discharge among 1,778 children in the original randomised trial
(Berkley et al., 2016). A secondary analysis of this data focusing on
life‐threatening events reported 823 life‐threatening events (257 fatal
and 566 nonfatal events) among 612 children after discharge from the
hospital (Ngari et al., 2018a), including a high rate of events in those
who had recovered their nutritional status. However, these reports
did not focus on the children who specifically readmitted with cSAM.
In this current study, we found that that by 1 year discharge, the risk
of any readmission with cSAM is 12%, which we believe is within the
range that would be reasonably anticipated in a poor, food‐insecure
population.
This is the first report that assessed the association between SAM
phenotype at index admission with the phenotype at succeeding
readmissions. The randomised control trial had a very low dropout
rate (5%); as such, we were able to capture multiple readmissions of
children even for those who were readmitted to different hospitals.
However, because the randomised trial did not include children with
HIV, we cannot generalise the study results on readmission rates to
children with SAM and HIV, a common feature in Africa, with a known
elevated mortality and deterioration risk (Kerac et al., 2014). Further-
more, we were unable to assess compliance to outpatient therapeutic
programme.
Systematic HIV screening at the KCH was implemented in 2007, as
such, some of the children included in the KCH data analysis were
known to have HIV. However, since we only performed passive
follow‐up on these children, readmission rates, including those to
other hospitals, could not be reliably not estimated. Furthermore,
because these children were not actively followed, we only considered
a readmission when it occurred at least 2 months after the previous
hospital discharge.5 | CONCLUSION
This is the first report of hospital readmissions with cSAM showing
that SAM phenotype at index admission is sustained at succeeding
readmissions with cSAM.ACKNOWLEDGMENTS
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